Michael Hammer
Neurology with Special Qualifications in Child Neurology · Saint Petersburg, FLNPI 1508808759
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $77,980 of the $100,246 with a category attached, or 77.8%. 14 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 51.8% of the total. Reporting peaked in 2019 at $41,528 and has fallen 99.5% since, to $208 in 2025. Among neurology with special qualifications in child neurology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 396 payments — averaging $253.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$52K
- Supernus Pharmaceuticals, Inc.$29K
- UCB, Inc.$17K
- Livanova USA, Inc.$518
- Eisai Inc.$493
- Neurelis, Inc.$449
- plus $935 from 8 others
What the payments were for
- Consulting fees$9,4009%
- Speaking & faculty fees$77,98078%
- Travel & lodging$5,0175%
- Food & beverage$7,8428%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 92 | $51,919 |
| Supernus Pharmaceuticals, Inc. | 140 | $29,415 |
| UCB, Inc. | 66 | $16,517 |
| Livanova USA, Inc. | 13 | $518 |
| Eisai Inc. | 17 | $493 |
| Neurelis, Inc. | 17 | $449 |
| Corium, LLC | 13 | $285 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $240 |
| Greenwich Biosciences, Inc. | 4 | $141 |
| Shire North American Group Inc | 12 | $128 |
| Tris Pharma Inc | 4 | $54 |
| Mallinckrodt Enterprises LLC | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Catalyst Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$38,861
- QELBREE$27,610
- JORNAY PM$11,500
- Briviact$4,624
- Nayzilam$4,424
- Fintepla$369
- VNS Therapy$355
- Azstarys$112
- VALTOCO$105
- Fycompa$104
How this compares
$100,246 in reported general payments places this provider in the 90th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Saint Petersburg
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ronald DavisWinter Park$154K
- Ian MillerMiami$104K
- Matt LallasMiami$88K
- Jose FerreiraTampa$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.